Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-128-3 | CAS number: 556-52-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not documented
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets generally accepted scientific principles, acceptable for assessment.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- The toxicology of glycidol and some glycidyl ethers
- Author:
- Hine, C.H. et al.
- Year:
- 1 956
- Bibliographic source:
- Arch. Ind. Health 14, 250-264 (1956)
- Report date:
- 1956
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Vapor exposure - In these experiments graded concentrations of the compounds were used when death was produced with exposures to concentrated vapour. The term "saturated vapor" is not used, since in the author's experience the theoretical concentration at saturation is frequently not obtained.
The concentrated vapors approached theoretical saturation, however, except with DGE, where, owing to a small volume of sample, only about 200 ppm, was obtained.
Four-hour period. Groups of five or six mice (20 to 28 gm.) Were exposed to graded concentrations of the vapors of glycidol, AGE, and IGE at 30±1 C and to DGE at room temperature (25±1 C) for four hours in a glass chamber of 19.5 liters capacity. The motor-driven syringe assembly previously describcd by Hine and associates delivered measured amounts of the test compound from a 10 mL Luer-Lok syringe into an evaporator through which metered air moved at a uniform rate. The air flow was set at approximately 3 to 11 liters per minute, depending on the concentration desired. Nominal concentrations were calculated by the standard gas-concentration formula of Jacobs; and were checkcd by determining the total quantity of material vaporized.
Eight-hour period. Groups of six rats ( 110-140 gm.) were exposed to graded concentrations of glycidol, AGE, llGE, and IGE, with temperatures and apparatus as , described above. Groups of six rats were also exposed for eight hours to concentrated vapours of MCH, DGE, and PGE, using temperatures and apparatus as described above. - GLP compliance:
- no
- Remarks:
- study prior to adoption of GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2,3-epoxypropan-1-ol
- EC Number:
- 209-128-3
- EC Name:
- 2,3-epoxypropan-1-ol
- Cas Number:
- 556-52-5
- Molecular formula:
- C3H6O2
- IUPAC Name:
- (oxiran-2-yl)methanol
- Details on test material:
- - Name of test material (as cited in study report): Glycidol
- Molecular weight (if other than submission substance): 74.05
- Physical state: Liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Long-Evans
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: commercial laboratory in Gilroy, California
- Age at study initiation: Not documented
- Weight at study initiation: 110 - 140g
- Fasting period before study: Not documented
- Housing: 5 or 6 to a cage.
- Diet (e.g. ad libitum): standard laboratory pellets.
- Water (e.g. ad libitum): Not documented
- Acclimation period: Not documented
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Not documented
- Humidity (%): Not documented
- Air changes (per hr): Not documented
- Photoperiod (hrs dark / hrs light): Not documented
IN-LIFE DATES: From: To: Not documented
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- not specified
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Glass chamber
- Exposure chamber volume: 19.5L
- Method of holding animals in test chamber: Not documented
- Source and rate of air: The air flow was set at a rate of approximately 3 to 11 L/minute, depending on the desired concentration. A motor-driven syringe assembly delivered measured amounts of the test compound from a 10ml Luer-Lok syringe into an evaporator through which metered air moved at a uniform rate.
- Method of conditioning air: No information provided
- System of generating particulates/aerosols: No information provided
- Method of particle size determination: No information provided
- Treatment of exhaust air: Not documented
- Temperature, humidity, pressure in air chamber: Temperature: 30 ± 1°
TEST ATMOSPHERE
- Brief description of analytical method used: Nominal concentrations were calculated by the standard gas-concentration formula of Jacobs and were checked by determining the total quantity of material vaporized.
- Samples taken from breathing zone: not documented
VEHICLE
- Composition of vehicle (if applicable): not documented
- Concentration of test material in vehicle (if applicable): not documented
- Justification of choice of vehicle: not documented
- Lot/batch no. (if required): not documented
- Purity: not documented
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: not documented
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): not documented - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 8 h
- Concentrations:
- not documented
- No. of animals per sex per dose:
- 6
- Control animals:
- not specified
- Details on study design:
- Test animals were observed for 10 days post-treatment for signs of test-substance related effects.
- Statistics:
- Litchfield and Wilcoxon
Results and discussion
- Preliminary study:
- Not documented
Effect levels
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 580 ppm
- Exp. duration:
- 8 h
- Mortality:
- not documented
- Clinical signs:
- other: Signs of intoxication: dyspnea, lacrimation, salivation, nasal discharge, aerophagia, terminal CNS depression but also signs of stimulation, death due to pulmonary edema. Corneal opacity was also observed following the 8 hour exposure.
- Body weight:
- not documented
- Gross pathology:
- In the case of glycidol an inexplicable pulmonary emphysema was also detected.
- Other findings:
- The commonest pathological finding was irritation of the lungs, and pneumonitis was confirmed by microscopic examination.
Any other information on results incl. tables
The concentration level of 580 ppm is equivalent to 1.75 mg/L.
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- In this acute inhalation toxicity study in rats the LD50 of 580 ppm (1.75 mg/L /8h) was determined. Under the conditions of this study, the test substance should be classified as a Category II toxicant according to Regulation EC No. 1272/2008 and should have the signal word Danger and the hazard statement H330: Fatal if inhaled associated with it. According to Directive 67/548/EEC, the test substance should be classified as R23, toxic by inhalation since the LC50 was between 0.5 and 2.0 mg/L - the limits for a vapour to warrant R23.
- Executive summary:
In a study conducted by Hine et al in 1956, the test substance, Glycidol, was tested for its ability to acute cause toxicity when administered to male Long Evan rats via whole-body inhalation. The test animals were exposed to the test substance for a period of 8 hours and the animals were observed for effects for 10 days post-treatment. Following this observation period, signs of intoxication included dyspnea, lacrimation, salivation, nasal discharge, aerophagia, terminal CNS depression but also signs of stimulation, with death usually caused by pulmonary oedema. The commonest pathological finding was irritation of the lungs, and pneumonitis was confirmed by microscopic examination and an inexplicable case of pulmonary emphysema was also recorded. Based on the results of this study, the LD50 was determined to be 580ppm. Under the conditions of this study, the test substance should be classified as a Category II toxicant according to Regulation EC No. 1272/2008 and should have the signal word Danger and the hazard statement H330: Fatal if inhaled associated with it. According to Directive 67/548/EEC, the test substance should be classified as R23, Toxic by inhalation
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.